Concepts (82)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| HIV Infections | 6 | 2015 | 369 | 1.240 |
Why?
|
| Liver Cirrhosis | 4 | 2015 | 34 | 1.130 |
Why?
|
| Hepatitis C | 3 | 2015 | 35 | 0.990 |
Why?
|
| Ageusia | 1 | 2022 | 1 | 0.800 |
Why?
|
| Hepatitis C, Chronic | 2 | 2015 | 39 | 0.570 |
Why?
|
| CD4-Positive T-Lymphocytes | 2 | 2015 | 61 | 0.530 |
Why?
|
| Thromboplastin | 1 | 2015 | 5 | 0.480 |
Why?
|
| CD8-Positive T-Lymphocytes | 2 | 2013 | 64 | 0.430 |
Why?
|
| Interleukin-10 | 1 | 2013 | 15 | 0.430 |
Why?
|
| Herpes Zoster | 1 | 2013 | 3 | 0.420 |
Why?
|
| Lymphocyte Activation | 1 | 2013 | 44 | 0.420 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2013 | 139 | 0.380 |
Why?
|
| Coinfection | 4 | 2015 | 17 | 0.290 |
Why?
|
| Blastomycosis | 1 | 2005 | 23 | 0.240 |
Why?
|
| Cross-Sectional Studies | 3 | 2015 | 713 | 0.210 |
Why?
|
| Adult | 6 | 2015 | 6584 | 0.200 |
Why?
|
| Spike Glycoprotein, Coronavirus | 1 | 2022 | 11 | 0.200 |
Why?
|
| Antibody Formation | 1 | 2022 | 12 | 0.200 |
Why?
|
| Cough | 1 | 2022 | 9 | 0.200 |
Why?
|
| Antibodies, Viral | 1 | 2022 | 46 | 0.200 |
Why?
|
| Middle Aged | 6 | 2015 | 7555 | 0.190 |
Why?
|
| Biomarkers | 2 | 2015 | 453 | 0.190 |
Why?
|
| RNA, Messenger | 1 | 2022 | 254 | 0.190 |
Why?
|
| Neurosyphilis | 1 | 2021 | 3 | 0.180 |
Why?
|
| Treponema pallidum | 1 | 2021 | 3 | 0.180 |
Why?
|
| Humans | 9 | 2022 | 22848 | 0.180 |
Why?
|
| HIV-1 | 2 | 2013 | 166 | 0.170 |
Why?
|
| Viral Load | 3 | 2015 | 65 | 0.160 |
Why?
|
| Female | 6 | 2015 | 12677 | 0.150 |
Why?
|
| Hepacivirus | 2 | 2015 | 26 | 0.150 |
Why?
|
| Elasticity Imaging Techniques | 2 | 2015 | 8 | 0.140 |
Why?
|
| Male | 4 | 2015 | 12453 | 0.130 |
Why?
|
| Receptors, Immunologic | 1 | 2015 | 24 | 0.120 |
Why?
|
| Interleukin-6 | 1 | 2015 | 60 | 0.120 |
Why?
|
| CD4 Lymphocyte Count | 1 | 2015 | 42 | 0.120 |
Why?
|
| Flow Cytometry | 1 | 2015 | 75 | 0.120 |
Why?
|
| Liver | 1 | 2015 | 127 | 0.110 |
Why?
|
| HLA-DR Antigens | 1 | 2013 | 8 | 0.110 |
Why?
|
| Herpes Zoster Vaccine | 1 | 2013 | 2 | 0.110 |
Why?
|
| Herpesvirus 3, Human | 1 | 2013 | 4 | 0.110 |
Why?
|
| Antiretroviral Therapy, Highly Active | 1 | 2013 | 51 | 0.110 |
Why?
|
| Ultrasonography | 1 | 2015 | 205 | 0.100 |
Why?
|
| Health Care Surveys | 1 | 2013 | 57 | 0.100 |
Why?
|
| Life Style | 1 | 2013 | 127 | 0.100 |
Why?
|
| Attitude of Health Personnel | 1 | 2013 | 127 | 0.090 |
Why?
|
| Incidence | 1 | 2013 | 649 | 0.090 |
Why?
|
| Genes, MHC Class I | 1 | 2010 | 4 | 0.090 |
Why?
|
| HLA-B Antigens | 1 | 2010 | 6 | 0.090 |
Why?
|
| Antigen Presentation | 1 | 2010 | 9 | 0.090 |
Why?
|
| Chicago | 1 | 2013 | 808 | 0.090 |
Why?
|
| Surveys and Questionnaires | 1 | 2013 | 977 | 0.080 |
Why?
|
| United States | 1 | 2013 | 1726 | 0.070 |
Why?
|
| Aged | 2 | 2013 | 7669 | 0.070 |
Why?
|
| Illinois | 1 | 2005 | 211 | 0.060 |
Why?
|
| Child, Preschool | 1 | 2005 | 489 | 0.050 |
Why?
|
| Severity of Illness Index | 2 | 2015 | 685 | 0.050 |
Why?
|
| Child | 1 | 2005 | 990 | 0.050 |
Why?
|
| Syphilis Serodiagnosis | 1 | 2021 | 2 | 0.050 |
Why?
|
| Fluorescent Treponemal Antibody-Absorption Test | 1 | 2021 | 2 | 0.050 |
Why?
|
| Point-of-Care Testing | 1 | 2021 | 28 | 0.040 |
Why?
|
| Prospective Studies | 2 | 2015 | 1528 | 0.040 |
Why?
|
| Adolescent | 1 | 2005 | 1775 | 0.040 |
Why?
|
| Cohort Studies | 2 | 2015 | 1621 | 0.040 |
Why?
|
| Aged, 80 and over | 1 | 2005 | 4055 | 0.030 |
Why?
|
| RNA, Viral | 1 | 2015 | 41 | 0.030 |
Why?
|
| Linear Models | 1 | 2015 | 205 | 0.030 |
Why?
|
| Multivariate Analysis | 1 | 2015 | 274 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2015 | 500 | 0.030 |
Why?
|
| HIV Long-Term Survivors | 1 | 2010 | 5 | 0.020 |
Why?
|
| HLA-C Antigens | 1 | 2010 | 7 | 0.020 |
Why?
|
| Amino Acids | 1 | 2010 | 19 | 0.020 |
Why?
|
| HIV Antigens | 1 | 2010 | 10 | 0.020 |
Why?
|
| HLA-A Antigens | 1 | 2010 | 13 | 0.020 |
Why?
|
| Protein Conformation | 1 | 2010 | 57 | 0.020 |
Why?
|
| Haplotypes | 1 | 2010 | 47 | 0.020 |
Why?
|
| Models, Molecular | 1 | 2010 | 60 | 0.020 |
Why?
|
| Immunity, Innate | 1 | 2010 | 53 | 0.020 |
Why?
|
| Alleles | 1 | 2010 | 173 | 0.020 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2010 | 233 | 0.020 |
Why?
|
| Logistic Models | 1 | 2010 | 320 | 0.020 |
Why?
|
| Genome-Wide Association Study | 1 | 2010 | 233 | 0.020 |
Why?
|
| Disease Progression | 1 | 2010 | 554 | 0.020 |
Why?
|